Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance

Oncogene volume 36, pages 3067–3079 (2017)Cite this article

Subjects

Abstract

The transmission of cellular information requires fine and subtle regulation of proteins that need to interact in a coordinated and specific way to form efficient signaling networks. The spatial and temporal coordination relies on scaffold proteins. Thanks to protein interaction domains such as PDZ domains, scaffold proteins organize multiprotein complexes enabling the proper transmission of cellular information through intracellular networks. NHERF1/EBP50 is a PDZ-scaffold protein that was initially identified as an organizer and regulator of transporters and channels at the apical side of epithelia through actin-binding ezrin-moesin-radixin proteins. Since, NHERF1/EBP50 has emerged as a major regulator of cancer signaling network by assembling cancer-related proteins. The PDZ-scaffold EBP50 carries either anti-tumor or pro-tumor functions, two antinomic functions dictated by EBP50 expression or subcellular localization. The dual function of NHERF1/EBP50 encompasses the regulation of several major signaling pathways engaged in cancer, including the receptor tyrosine kinases PDGFR and EGFR, PI3K/PTEN/AKT and Wnt-β-catenin pathways.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Good MC, Zalatan JG, Lim WA . Scaffold proteins: hubs for controlling the flow of cellular information. Science 2011; 332: 680–686.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Langeberg LK, Scott JD . Signalling scaffolds and local organization of cellular behaviour. Nat Rev Mol Cell Biol 2015; 16: 232–244.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Vondriska TM, Pass JM, Ping P . Scaffold proteins and assembly of multiprotein signaling complexes. J Mol Cell Cardiol 2004; 37: 391–397.

    Article  CAS  PubMed  Google Scholar 

  4. Dard N, Peter M . Scaffold proteins in MAP kinase signaling: more than simple passive activating platforms. Bioessays 2006; 28: 146–156.

    Article  CAS  PubMed  Google Scholar 

  5. Claperon A, Therrien M . KSR and CNK: two scaffolds regulating RAS-mediated RAF activation. Oncogene 2007; 26: 3143–3158.

    Article  CAS  PubMed  Google Scholar 

  6. Cortese MS, Uversky VN, Dunker AK . Intrinsic disorder in scaffold proteins: getting more from less. Prog Biophys Mol Biol 2008; 98: 85–106.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Hung AY, Sheng M . PDZ domains: structural modules for protein complex assembly. J Biol Chem 2002; 277: 5699–5702.

    Article  CAS  PubMed  Google Scholar 

  8. Nourry C, Grant SG, Borg JP . PDZ domain proteins: plug and play!. Sci STKE 2003; 2003: RE7.

    Article  PubMed  Google Scholar 

  9. Weinman EJ, Steplock D, Wang Y, Shenolikar S . Characterization of a protein cofactor that mediates protein kinase A regulation of the renal brush border membrane Na(+)-H+ exchanger. J Clin Invest 1995; 95: 2143–2149.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Reczek D, Berryman M, Bretscher A . Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J Cell Biol 1997; 139: 169–179.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Yun CH, Lamprecht G, Forster DV, Sidor A . NHE3 kinase A regulatory protein E3KARP binds the epithelial brush border Na+/H+ exchanger NHE3 and the cytoskeletal protein ezrin. J Biol Chem 1998; 273: 25856–25863.

    Article  CAS  PubMed  Google Scholar 

  12. Yun CH, Oh S, Zizak M, Steplock D, Tsao S, Tse CM et al. cAMP-mediated inhibition of the epithelial brush border Na+/H+ exchanger, NHE3, requires an associated regulatory protein. Proc Natl Acad Sci USA 1997; 94: 3010–3015.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Custer M, Spindler B, Verrey F, Murer H, Biber J . Identificationof a new gene product (diphor-1) regulated by dietary phosphate. Am J Physiol 1997; 273: F801–F806.

    CAS  PubMed  Google Scholar 

  14. Kocher O, Comella N, Gilchrist A, Pal R, Tognazzi K, Brown LF et al. PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein. Lab Invest 1999; 79: 1161–1170.

    CAS  PubMed  Google Scholar 

  15. Wang S, Yue H, Derin RB, Guggino WB, Li M . Accessory protein facilitated CFTR-CFTR interaction. a molecular mecanism to potentiate the chloride channel activity. Cell 2000; 103: 169–179.

    Article  CAS  PubMed  Google Scholar 

  16. Gisler SM, Stagljar I, Traebert M, Bacic D, Biber J, Murer H . Interaction of the type IIa Na/Pi cotransporter with PDZ proteins. J Biol Chem 2001; 276: 9206–9213.

    Article  CAS  PubMed  Google Scholar 

  17. Scott RO, Thelin WR, Milgram SL . A novel PDZ protein regulates the activity of guanylyl cyclase C, the heat-stable enterotoxin receptor. J Biol Chem 2002; 277: 22934–22941.

    Article  CAS  PubMed  Google Scholar 

  18. Weinman EJ, Steplock D, Shenolikar S . cAMP-mediated inhibition of the renal brush border membrane Na+-H+ exchanger requires a dissociable phosphoprotein cofactor. J Clin Invest 1993; 92: 1781–1786.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ediger TR, Kraus WL, Weinman EJ, Katzenellenbogen BS . Estrogen receptor regulation of the Na+/H+ exchange regulatory factor. Endocrinology 1999; 140: 2976–2982.

    Article  CAS  PubMed  Google Scholar 

  20. Fouassier L, Duan CY, Feranchak AP, Yun CH, Sutherland E, Simon F et al. Ezrin-radixin-moesin-binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia. Hepatology 2001; 33: 166–176.

    Article  CAS  PubMed  Google Scholar 

  21. Ingraffea J, Reczek D, Bretscher A . Distinct cell type-specific expression of scaffolding proteins EBP50 and E3KARP: EBP50 is generally expressed with ezrin in specific epithelia, whereas E3KARP is not. Eur J Cell Biol 2002; 81: 61–68.

    Article  CAS  PubMed  Google Scholar 

  22. Georgescu MM, Cote G, Agarwal NK, White CL 3rd . NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane. Neoplasia 2014; 16: e361–e362.

    Article  CAS  Google Scholar 

  23. Sheng R, Chen Y, Yung Gee H, Stec E, Melowic HR, Blatner NR et al. Cholesterol modulates cell signaling and protein networking by specifically interacting with PDZ domain-containing scaffold proteins. Nat Commun 2012; 3: 1249.

    Article  PubMed  CAS  Google Scholar 

  24. Hanono A, Garbett D, Reczek D, Chambers DN, Bretscher A . EPI64 regulates microvillar subdomains and structure. J Cell Biol 2006; 175: 803–813.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Chiba H, Sakai N, Murata M, Osanai M, Ninomiya T, Kojima T et al. The nuclear receptor hepatocyte nuclear factor 4alpha acts as a morphogen to induce the formation of microvilli. J Cell Biol 2006; 175: 971–980.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Garbett D, LaLonde DP, Bretscher A . The scaffolding protein EBP50 regulates microvillar assembly in a phosphorylation-dependent manner. J Cell Biol 2010; 191: 397–413.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Saotome I, Curto M, McClatchey AI . Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. Dev Cell 2004; 6: 855–864.

    Article  CAS  PubMed  Google Scholar 

  28. Voltz JW, Brush M, Sikes S, Steplock D, Weinman EJ, Shenolikar S . Phosphorylation of PDZI domain attenuates NHERF-1 binding to cellular targets. J Biol Chem 2007; 282: 33879–33887.

    Article  CAS  PubMed  Google Scholar 

  29. Morales FC, Takahashi Y, Kreimann EL, Georgescu MM . Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia. Proc Natl Acad Sci USA 2004; 101: 17705–17710.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Broere N, Chen M, Cinar A, Singh AK, Hillesheim J, Riederer B et al. Defective jejunal and colonic salt absorption and alteredNa(+)/H (+) exchanger 3 (NHE3) activity in NHE regulatory factor 1 (NHERF1) adaptor protein-deficient mice. Pflugers Arch 2009; 457: 1079–1091.

    Article  CAS  PubMed  Google Scholar 

  31. Georgescu MM, Gagea M, Cote G . NHERF1/EBP50 suppresses wnt-beta-catenin pathway-driven intestinal neoplasia. Neoplasia 2016; 18: 512–523.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Hayashi Y, Molina JR, Hamilton SR, Georgescu MM . NHERF1/EBP50 is a new marker in colorectal cancer. Neoplasia 2010; 12: 1013–1022.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Boratko A, Gergely P, Csortos C . Cell cycle dependent association of EBP50 with protein phosphatase 2A in endothelial cells. PLoS One 2012; 7: e35595.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Song GJ, Barrick S, Leslie KL, Bauer PM, Alonso V, Friedman PA et al. The scaffolding protein EBP50 promotes vascular smooth muscle cell proliferation and neointima formation by regulating Skp2 and p21(cip1). Arterioscler Thromb Vasc Biol 2012; 32: 33–41.

    Article  CAS  PubMed  Google Scholar 

  35. Song GJ, Leslie KL, Barrick S, Bougoin S, Taboas JM, Bisello A . EBP50 promotes focal adhesion turnover and vascular smooth muscle cells migration. J Mol Cell Cardiol 2012; 53: 809–819.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Baeyens N, de Meester C, Yerna X, Morel N . EBP50 is involved in the regulation of vascular smooth muscle cell migration and cytokinesis. J Cell Biochem 2011; 112: 2574–2584.

    Article  CAS  PubMed  Google Scholar 

  37. Georgescu MM, Yell P, Mobley BC, Shang P, Georgescu T, Wang SH et al. NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma. Acta Neuropathol Commun 2015; 3: 11.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Vitureira N, Andres R, Perez-Martinez E, Martinez A, Bribian A, Blasi J et al. Podocalyxin is a novel polysialylated neural adhesion protein with multiple roles in neural development and synapse formation. PLoS One 2010; 5: e12003.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  39. Rangwala R, Banine F, Borg JP, Sherman LS . Erbin regulates mitogen-activated protein (MAP) kinase activation and MAP kinase-dependent interactions between Merlin and adherens junction protein complexes in Schwann cells. J Biol Chem 2005; 280: 11790–11797.

    Article  CAS  PubMed  Google Scholar 

  40. Schroeder TM, Nair AK, Staggs R, Lamblin AF, Westendorf JJ . Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors. BMC Genomics 2007; 8: 362.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Liu L, Alonso V, Guo L, Tourkova I, Henderson SE, Almarza AJ et al. Na+/H+-exchange regulatory factor-1 (NHERF1) directly regulates osteogenesis. J Biol Chem 2012; 287: 43312–43321.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Tan PC, Furness SG, Merkens H, Lin S, McCoy ML, Roskelley CD et al. Na+/H+ exchanger regulatory factor-1 is a hematopoietic ligand for a subset of the CD34 family of stem cell surface proteins. Stem Cells 2006; 24: 1150–1161.

    Article  CAS  PubMed  Google Scholar 

  43. Yin G, Li J, Wan Y, Hou R, Li X, Zhang J et al. Abnormality of RUNX1 signal transduction in psoriatic CD34+ bone marrow cells. Br J Dermatol 2011; 164: 1043–1051.

    Article  CAS  PubMed  Google Scholar 

  44. Stalker TJ, Wu J, Morgans A, Traxler EA, Wang L, Chatterjee MS et al. Endothelial cell specific adhesion molecule (ESAM) localizes to platelet-platelet contacts and regulates thrombus formation in vivo. J Thromb Haemost 2009; 7: 1886–1896.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Itoh K, Sakakibara M, Yamasaki S, Takeuchi A, Arase H, Miyazaki M et al. Cutting edge: negative regulation of immune synapse formation by anchoring lipid raft to cytoskeleton through Cbp-EBP50-ERM assembly. J Immunol 2002; 168: 541–544.

    Article  CAS  PubMed  Google Scholar 

  46. Garcia GG, Sadighi Akha AA, Miller RA . Age-related defects in moesin/ezrin cytoskeletal signals in mouse CD4 T cells. J Immunol 2007; 179: 6403–6409.

    Article  CAS  PubMed  Google Scholar 

  47. Stokka AJ, Mosenden R, Ruppelt A, Lygren B, Tasken K . The adaptor protein EBP50 is important for localization of the protein kinase A-Ezrin complex in T-cells and the immunomodulating effect of cAMP. Biochem J 2010; 425: 381–388.

    Article  CAS  Google Scholar 

  48. Wu Y, Wang S, Farooq SM, Castelvetere MP, Hou Y, Gao JL et al. A chemokine receptor CXCR2 macromolecular complex regulates neutrophil functions in inflammatory diseases. J Biol Chem 2012; 287: 5744–5755.

    Article  CAS  PubMed  Google Scholar 

  49. Lacalle RA, Peregil RM, Albar JP, Merino E, Martinez AC, Merida I et al. Type I phosphatidylinositol 4-phosphate 5-kinase controls neutrophil polarity and directional movement. J Cell Biol 2007; 179: 1539–1553.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Leslie KL, Song GJ, Barrick S, Wehbi VL, Vilardaga JP, Bauer PM et al. Ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) and nuclear factor-kappaB (NF-kappaB): a feed-forward loop for systemic and vascular inflammation. J Biol Chem 2013; 288: 36426–36436.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS . Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 2003; 206: 13–22.

    Article  CAS  PubMed  Google Scholar 

  52. Ediger TR, Park SE, Katzenellenbogen BS . Estrogen receptor inducibility of the human Na+/H+ exchanger regulatory factor/ezrin-radixin-moesin binding protein 50 (NHE-RF/EBP50) gene involving multiple half-estrogen response elements. Mol Endocrinol 2002; 16: 1828–1839.

    Article  CAS  PubMed  Google Scholar 

  53. Fouassier L, Rosenberg P, Mergey M, Saubamea B, Claperon A, Kinnman N et al. Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation. Am J Pathol 2009; 174: 869–880.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Smith PM, Cowan A, Milgram SL, White BA . Tissue-specific regulation by estrogen of ezrin and ezrin/radixin/moesin-binding protein 50. Endocrine 2003; 22: 119–126.

    Article  CAS  PubMed  Google Scholar 

  55. Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M et al. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. J Steroid Biochem Mol Biol 2000; 74: 279–285.

    Article  CAS  PubMed  Google Scholar 

  56. Yang L, Wang Y, Chen P, Hu J, Xiong Y, Feng D et al. Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression. Endocrinology 2011; 152: 4537–4549.

    Article  CAS  PubMed  Google Scholar 

  57. Stemmer-Rachamimov AO, Wiederhold T, Nielsen GP, James M, Pinney-Michalowski D, Roy JE et al. NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas. Am J Pathol 2001; 158: 57–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Kremer KN, Dudakovic A, Hess AD, Smith BD, Karp JE, Kaufmann SH et al. Histone deacetylase inhibitors target the leukemic microenvironment by enhancing a nherf1-protein phosphatase 1alpha-taz signaling pathway in osteoblasts. J Biol Chem 2015; 290: 29478–29492.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Dudakovic A, Evans JM, Li Y, Middha S, McGee-Lawrence ME, van Wijnen AJ et al. Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation. J Biol Chem 2013; 288: 28783–28791.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Fouassier L, Nichols MT, Gidey E, McWilliams RR, Robin H, Finnigan C et al. Protein kinase C regulates the phosphorylation and oligomerization of ERM binding phosphoprotein 50. Exp Cell Res 2005; 306: 264–273.

    Article  CAS  PubMed  Google Scholar 

  61. Li J, Poulikakos PI, Dai Z, Testa JR, Callaway DJ, Bu Z . Protein kinase C phosphorylation disrupts Na+/H+ exchanger regulatory factor 1 autoinhibition and promotes cystic fibrosis transmembrane conductance regulator macromolecular assembly. J Biol Chem 2007; 282: 27086–27099.

    Article  CAS  PubMed  Google Scholar 

  62. Raghuram V, Hormuth H, Foskett JK . A kinase-regulated mechanism controls CFTR channel gating by disrupting bivalent PDZ domain interactions. Proc Natl Acad Sci USA 2003; 100: 9620–9625.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. He J, Lau AG, Yaffe MB, Hall RA . Phosphorylation and cell cycle-dependent regulation of Na+/H+ exchanger regulatory factor-1 by Cdc2 kinase. J Biol Chem 2001; 276: 41559–41565.

    Article  CAS  PubMed  Google Scholar 

  64. Hall RA, Spurney RF, Premont RT, Rahman N, Blitzer JT, Pitcher JA et al. G protein-coupled receptor kinase 6A phosphorylates the Na(+)/H(+) exchanger regulatory factor via a PDZ domain-mediated interaction. J Biol Chem 1999; 274: 24328–24334.

    Article  CAS  PubMed  Google Scholar 

  65. Song GJ, Leslie KL, Barrick S, Mamonova T, Fitzpatrick JM, Drombosky KW et al. Phosphorylation of ezrin-radixin-moesin-binding phosphoprotein 50 (ebp50) by akt promotes stability and mitogenic function of s-phase kinase-associated protein-2 (Skp2). J Biol Chem 2015; 290: 2879–2887.

    Article  CAS  PubMed  Google Scholar 

  66. Lim H, Jou TS . Ras-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferation. Oncotarget 2016; 7: 10283–10296.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Morales FC, Takahashi Y, Momin S, Adams H, Chen X, Georgescu MM . NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands. Mol Cell Biol 2007; 27: 2527–2537.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Cheng H, Li J, Fazlieva R, Dai Z, Bu Z, Roder H . Autoinhibitory interactions between the PDZ2 and C-terminal domains in the scaffolding protein NHERF1. Structure 2009; 17: 660–669.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Sun C, Zheng J, Cheng S, Feng D, He J . EBP50 phosphorylation by Cdc2/Cyclin B kinase affects actin cytoskeleton reorganization and regulates functions of human breast cancer cell line MDA-MB-231. Mol Cells 2013; 36: 47–54.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  70. Sun L, Zheng J, Wang Q, Song R, Liu H, Meng R et al. NHERF1 regulates actin cytoskeleton organization through modulation of alpha-actinin-4 stability. Faseb J 2016; 30: 578–589.

    Article  CAS  PubMed  Google Scholar 

  71. Fouassier L, Yun CC, Fitz JG, Doctor RB . Evidence for ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) self-association through PDZ-PDZ interactions. J Biol Chem 2000; 275: 25039–25045.

    Article  CAS  PubMed  Google Scholar 

  72. Shenolikar S, Minkoff CM, Steplock DA, Evangelista C, Liu M, Weinman EJ, N-terminal PDZ . Domain is required for NHERF dimerization. FEBS Lett 2001; 489: 233–236.

    Article  CAS  PubMed  Google Scholar 

  73. Lau AG, Hall RA . Oligomerization of NHERF-1 and NHERF-2 PDZ domains: differential regulation by association with receptor carboxyl-termini and by phosphorylation. Biochemistry 2001; 40: 8572–8580.

    Article  CAS  PubMed  Google Scholar 

  74. Maudsley S, Zamah AM, Rahman N, Blitzer JT, Luttrell LM, Lefkowitz RJ et al. Platelet-derived growth factor receptor association with Na(+)/H(+) exchanger regulatory factor potentiates receptor activity. Mol Cell Biol 2000; 20: 8352–8363.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Chen JY, Lin YY, Jou TS . Phosphorylation of EBP50 negatively regulates beta-PIX-dependent Rac1 activity in anoikis. Cell Death Differ 2012; 19: 1027–1037.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Bryant DM, Roignot J, Datta A, Overeem AW, Kim M, Yu W et al. A molecular switch for the orientation of epithelial cell polarization. Dev Cell 2014; 31: 171–187.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Weinman EJ, Steplock D, Zhang Y, Biswas R, Bloch RJ, Shenolikar S . Cooperativity between the phosphorylation of Thr95 and Ser77 of NHERF-1 in the hormonal regulation of renal phosphate transport. J Biol Chem 2010; 285: 25134–25138.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Weinman EJ, Biswas R, Steplock D, Douglass TS, Cunningham R, Shenolikar S . Sodium-hydrogen exchanger regulatory factor 1 (NHERF-1) transduces signals that mediate dopamine inhibition of sodium-phosphate co-transport in mouse kidney. J Biol Chem 2010; 285: 13454–13460.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Fang XY, Song R, Chen W, Yang YY, Gu YH, Shu YQ et al. PRL-3 promotes the malignant progression of melanoma via triggering dephosphorylation and cytoplasmic localization of NHERF1. J Invest Dermatol 2015; 135: 2273–2282.

    Article  CAS  PubMed  Google Scholar 

  80. Weinman EJ, Hall RA, Friedman PA, Liu-Chen LY, Shenolikar S . The association of NHERF adaptor proteins with g protein-coupled receptors and receptor tyrosine kinases. Annu Rev Physiol 2006; 68: 491–505.

    Article  CAS  PubMed  Google Scholar 

  81. Meng R, Qin Q, Xiong Y, Wang Y, Zheng J, Zhao Y et al. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer. Oncotarget e-pub ahead of print 19 July 2016 doi:10.18632/oncotarget.10713.

  82. Jiang Y, Wang S, Holcomb J, Trescott L, Guan X, Hou Y et al. Crystallographic analysis of NHERF1-PLCbeta3 interaction provides structural basis for CXCR2 signaling in pancreatic cancer. Biochem Biophys Res Commun 2014; 446: 638–643.

    Article  CAS  PubMed  Google Scholar 

  83. Wang S, Wu Y, Hou Y, Guan X, Castelvetere MP, Oblak JJ et al. CXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growth. Transl Oncol 2013; 6: 216–225.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Lu G, Wu Y, Jiang Y, Wang S, Hou Y, Guan X et al. Structural insights into neutrophilic migration revealed by the crystal structure of the chemokine receptor CXCR2 in complex with the first PDZ domain of NHERF1. PLoS One 2013; 8: e76219.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Wheeler DS, Barrick SR, Grubisha MJ, Brufsky AM, Friedman PA, Romero G . Direct interaction between NHERF1 and Frizzled regulates beta-catenin signaling. Oncogene 2011; 30: 32–42.

    Article  CAS  PubMed  Google Scholar 

  86. Lazar CS, Cresson CM, Lauffenburger DA, Gill GN . The Na+/H+ exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface. Mol Biol Cell 2004; 15: 5470–5480.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Takahashi Y, Morales FC, Kreimann EL, Georgescu MM . PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO J 2006; 25: 910–920.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Demoulin JB, Seo JK, Ekman S, Grapengiesser E, Hellman U, Ronnstrand L et al. Ligand-induced recruitment of Na+/H+-exchanger regulatory factor to the PDGF (platelet-derived growth factor) receptor regulates actin cytoskeleton reorganization by PDGF. Biochem J 2003; 376: 505–510.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Pan Y, Weinman EJ, Dai J . NHERF1 (Na+/H+ exchanger regulatory factor 1) inhibits platelet-derived growth factor signaling in breast cancer cells. Breast Cancer Res 2008; 10: R5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  90. Li H, Zhang B, Liu Y, Yin C . EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway. Med Oncol 2014; 31: 162.

    Article  PubMed  CAS  Google Scholar 

  91. Bellizzi A, Greco MR, Rubino R, Paradiso A, Forciniti S, Zeeberg K et al. The scaffolding protein NHERF1 sensitizes EGFR-dependent tumor growth, motility and invadopodia function to gefitinib treatment in breast cancer cells. Int J Oncol 2015; 46: 1214–1224.

    Article  CAS  PubMed  Google Scholar 

  92. Peng Z, Wang Q, Zhang Y, He J, Zheng J . EBP50 interacts with EGFR and regulates EGFR signaling to affect the prognosis of cervical cancer patients. Int J Oncol 2016; 49: 1737–1745.

    Article  CAS  PubMed  Google Scholar 

  93. Yao W, Feng D, Bian W, Yang L, Li Y, Yang Z et al. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation. Amino Acids 2012; 43: 2027–2035.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Claperon A, Guedj N, Mergey M, Vignjevic D, Desbois-Mouthon C, Boissan M et al. Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells. Oncogene 2012; 31: 1376–1388.

    Article  CAS  PubMed  Google Scholar 

  95. Georgescu MM . NHERF1: molecular brake on the PI3K pathway in breast cancer. Breast Cancer Res 2008; 10: 106.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  96. Brognard J, Sierecki E, Gao T, Newton AC . PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 2007; 25: 917–931.

    Article  CAS  PubMed  Google Scholar 

  97. Gao T, Furnari F, Newton AC . PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 2005; 18: 13–24.

    Article  CAS  PubMed  Google Scholar 

  98. Molina JR, Agarwal NK, Morales FC, Hayashi Y, Aldape KD, Cote G et al. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Oncogene 2012; 31: 1264–1274.

    Article  CAS  PubMed  Google Scholar 

  99. Wang B, Yang Y, Friedman PA . Na/H Exchange regulatory factor 1, a novel akt-associating protein, regulates extracellular signal-regulated kinase signaling through a B-raf-mediated pathway. Mol Biol Cell 2008; 19: 1637–1645.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Nguyen Ho-Bouldoires TH, Claperon A, Mergey M, Wendum D, Desbois-Mouthon C, Tahraoui S et al. Mitogen-activated protein kinase-activated protein kinase 2 mediates resistance to hydrogen peroxide-induced oxidative stress in human hepatobiliary cancer cells. Free Radic Biol Med 2015; 89: 34–46.

    Article  CAS  PubMed  Google Scholar 

  101. Vazquez F, Ramaswamy S, Nakamura N, Sellers WR . Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 2000; 20: 5010–5018.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Georgescu MM, Kirsch KH, Akagi T, Shishido T, Hanafusa H . The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. Proc Natl Acad Sci USA 1999; 96: 10182–10187.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Molina JR, Morales FC, Hayashi Y, Aldape KD, Georgescu MM . Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation. Cancer Res 2010; 70: 6697–6703.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Cardone RA, Greco MR, Capulli M, Weinman EJ, Busco G, Bellizzi A et al. NHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domains. Mol Biol Cell 2012; 23: 2028–2040.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Kostenko S, Moens U . Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci 2009; 66: 3289–3307.

    Article  CAS  PubMed  Google Scholar 

  106. Rane MJ, Pan Y, Singh S, Powell DW, Wu R, Cummins T et al. Heat shock protein 27 controls apoptosis by regulating Akt activation. J Biol Chem 2003; 278: 27828–27835.

    Article  CAS  PubMed  Google Scholar 

  107. Weber HO, Ludwig RL, Morrison D, Kotlyarov A, Gaestel M, Vousden KH . HDM2 phosphorylation by MAPKAP kinase 2. Oncogene 2005; 24: 1965–1972.

    Article  CAS  PubMed  Google Scholar 

  108. Rane MJ, Coxon PY, Powell DW, Webster R, Klein JB, Pierce W et al. p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J Biol Chem 2001; 276: 3517–3523.

    Article  CAS  PubMed  Google Scholar 

  109. Shibata T, Chuma M, Kokubu A, Sakamoto M, Hirohashi S . EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology 2003; 38: 178–186.

    Article  CAS  PubMed  Google Scholar 

  110. Kreimann EL, Morales FC, de Orbeta-Cruz J, Takahashi Y, Adams H, Liu TJ et al. Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function. Oncogene 2007; 26: 5290–5299.

    Article  CAS  PubMed  Google Scholar 

  111. Lin YY, Hsu YH, Huang HY, Shann YJ, Huang CY, Wei SC et al. Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and beta-catenin interactions. J Clin Invest 2012; 122: 1881–1894.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Paradiso A, Scarpi E, Malfettone A, Addati T, Giotta F, Simone G et al. Nuclear NHERF1 expression as a prognostic marker in breast cancer. Cell Death Dis 2013; 4: e904.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Murthy A, Gonzalez-Agosti C, Cordero E, Pinney D, Candia C, Solomon F et al. NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins. J Biol Chem 1998; 273: 1273–1276.

    Article  CAS  PubMed  Google Scholar 

  114. Gonzales-Agosti C, Wiederhold T, Herndon ME, Gusella J, Ramesh V . Interdomain interaction of merlin isoforms and tis influence on intermolecular binding to NHE-RF. J Biol Chem 1999; 274: 34438–34442.

    Article  Google Scholar 

  115. Nguyen R, Reczek D, Bretscher A . Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP. J Biol Chem 2001; 276: 7621–7629.

    Article  CAS  PubMed  Google Scholar 

  116. Curto M, Cole BK, Lallemand D, Liu CH, McClatchey AI . Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol 2007; 177: 893–903.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. Abeysundara N, Leung AC, Primrose DA, Hughes SC . Regulation of cell proliferation and adhesion by means of a novel region of drosophila merlin interacting with Sip1. Dev Dyn 2014; 243: 1554–1570.

    Article  CAS  PubMed  Google Scholar 

  118. Hughes SC, Formstecher E, Fehon RG . Sip1, the Drosophila orthologue of EBP50/NHERF1, functions with the sterile 20 family kinase Slik to regulate Moesin activity. J Cell Sci 2010; 123: 1099–1107.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. Cardone RA, Bellizzi A, Busco G, Weinman EJ, Dell'Aquila ME, Casavola V et al. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. Mol Biol Cell 2007; 18: 1768–1780.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Garcia-Mata R, Burridge K . Catching a GEF by its tail. Trend Cell Biol 2007; 17: 36–43.

    Article  CAS  Google Scholar 

  121. Hsu YH, Lin WL, Hou YT, Pu YS, Shun CT, Chen CL et al. Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7. Am J Pathol 2010; 176: 3050–3061.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Liu H, Ma Y, He HW, Wang JP, Jiang JD, Shao RG . SLC9A3R1 stimulates autophagy via BECN1 stabilization in breast cancer cells. Autophagy 2015; 11: 2323–2334.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  123. Karn T, Ruckhaberle E, Hanker L, Muller V, Schmidt M, Solbach C et al. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance. Breast Cancer Res Treat 2011; 130: 409–420.

    Article  CAS  PubMed  Google Scholar 

  124. Song J, Bai J, Yang W, Gabrielson EW, Chan DW, Zhang Z . Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer. Histopathology 2007; 51: 40–53.

    Article  CAS  PubMed  Google Scholar 

  125. Malfettone A, Saponaro C, Paradiso A, Simone G, Mangia A . Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis. BMC Cancer 2012; 12: 106.

    Article  PubMed  PubMed Central  Google Scholar 

  126. Mangia A, Chiriatti A, Bellizzi A, Malfettone A, Stea B, Zito FA et al. Biological role of NHERF1 protein expression in breast cancer. Histopathology 2009; 55: 600–608.

    Article  PubMed  Google Scholar 

  127. Bellizzi A, Mangia A, Malfettone A, Cardone RA, Simone G, Reshkin SJ et al. Na+/H+ exchanger regulatory factor 1 expression levels in blood and tissue predict breast tumour clinical behaviour. Histopathology 2011; 58: 1086–1095.

    Article  PubMed  Google Scholar 

  128. Mangia A, Malfettone A, Saponaro C, Tommasi S, Simone G, Paradiso A . Human epidermal growth factor receptor 2, Na+/H+ exchanger regulatory factor 1, and breast cancer susceptibility gene-1 as new biomarkers for familial breast cancers. Hum Pathol 2011; 42: 1589–1595.

    Article  CAS  PubMed  Google Scholar 

  129. Cornez I, Tasken K . Spatiotemporal control of cyclic AMP immunomodulation through the PKA-Csk inhibitory pathway is achieved by anchoring to an Ezrin-EBP50-PAG scaffold in effector T cells. FEBS Lett 2010; 584: 2681–2688.

    Article  CAS  PubMed  Google Scholar 

  130. Dai JL, Wang L, Sahin AA, Broemeling LD, Schutte M, Pan Y . NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer. Oncogene 2004; 23: 8681–8687.

    Article  PubMed  CAS  Google Scholar 

  131. Du G, Hao C, Gu Y, Wang Z, Jiang WG, He J et al. A novel NHERF1 mutation in human breast cancer inactivates inhibition by NHERF1 protein in EGFR signaling. Anticancer Res 2016; 36: 1165–1173.

    CAS  PubMed  Google Scholar 

  132. Cheng S, Li Y, Yang Y, Feng D, Yang L, Ma Q et al. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling. FEBS Lett 2013; 587: 3289–3295.

    Article  CAS  PubMed  Google Scholar 

  133. Tabrizi AD, Kalloger SE, Kobel M, Cipollone J, Roskelley CD, Mehl E et al. Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases. Int J Gynecol Pathol 2010; 29: 99–107.

    Article  PubMed  Google Scholar 

  134. Accardi R, Rubino R, Scalise M, Gheit T, Shahzad N, Thomas M et al. E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1. J Virol 2011; 85: 8208–8216.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Kreimann EL, Ratajska M, Kuzniacka A, Demacopulo B, Stukan M, Limon J . A novel splicing mutation in the SLC9A3R1 gene in tumors from ovarian cancer patients. Oncol Lett 2015; 10: 3722–3726.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  136. Bartholow TL, Becich MJ, Chandran UR, Parwani AV . Immunohistochemical analysis of ezrin-radixin-moesin-binding phosphoprotein 50 in prostatic adenocarcinoma. BMC Urol 2011; 11: 12.

    Article  PubMed  PubMed Central  Google Scholar 

  137. Wang L, Du YR, Ji MY, Wang W, Zhan N, Zhou QS et al. Reduced EBP50 expression or mis-localization of the EBP50 protein is associated with the malignant progression of esophageal squamous cell carcinoma. Eur Rev Med Pharmacol Sci 2014; 18: 3854–3863.

    CAS  PubMed  Google Scholar 

  138. Mangia A, Caldarola L, Dell'Endice S, Scarpi E, Saragoni L, Monti M et al. The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy. Cancer Biol Ther 2015; 16: 1140–1147.

    Article  PubMed  PubMed Central  Google Scholar 

  139. Ji MY, Fan DK, Lv XG, Peng XL, Lei XF, Dong WG . The detection of EBP50 expression using quantum dot immunohistochemistry in pancreatic cancer tissue and down-regulated EBP50 effect on PC-2 cells. J Mol Histol 2012; 43: 517–526.

    Article  CAS  PubMed  Google Scholar 

  140. Malfettone A, Silvestris N, Paradiso A, Mattioli E, Simone G, Mangia A . Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype. Exp Mol Pathol 2012; 92: 296–303.

    Article  CAS  PubMed  Google Scholar 

  141. Mangia A, Saponaro C, Malfettone A, Bisceglie D, Bellizzi A, Asselti M et al. Involvement of nuclear NHERF1 in colorectal cancer progression. Oncol Rep 2012; 28: 889–894.

    Article  PubMed  Google Scholar 

  142. Schirosi L, Mazzotta A, Opinto G, Pinto R, Graziano G, Tommasi S et al. Beta-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients. Oncotarget e-pub ahead of print 27 September 2016 doi:10.18632/oncotarget.12280.

  143. Yonglitthipagon P, Pairojkul C, Chamgramol Y, Loukas A, Mulvenna J, Bethony J et al. Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma. Hum Pathol 2012; 43: 1719–1730.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  144. Kislin KL, McDonough WS, Eschbacher JM, Armstrong BA, Berens ME . NHERF-1: modulator of glioblastoma cell migration and invasion. Neoplasia 2009; 11: 377–387.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  145. Mangia A, Partipilo G, Schirosi L, Saponaro C, Galetta D, Catino A et al. Fine needle aspiration cytology: a tool to study nherf1 expression as a potential marker of aggressiveness in lung cancer. Mol Biotechnol 2015; 57: 549–557.

    Article  CAS  PubMed  Google Scholar 

  146. Lee HH, Wang YN, Hung MC . Non-canonical signaling mode of the epidermal growth factor receptor family. Am J Cancer Res 2015; 5: 2944–2958.

    CAS  PubMed  PubMed Central  Google Scholar 

  147. Kishore R, Qin G, Luedemann C, Bord E, Hanley A, Silver M et al. The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A. J Clin Invest 2005; 115: 1785–1796.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  148. Beltrami S, Kim R, Gordon J . Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator. Anticancer Res 2013; 33: 1–11.

    CAS  PubMed  PubMed Central  Google Scholar 

  149. Song MS, Salmena L, Pandolfi PP . The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 2012; 13: 283–296.

    Article  CAS  PubMed  Google Scholar 

  150. Meng W, Swenson LL, Fitzgibbon MJ, Hayakawa K, Ter Haar E, Behrens AE et al. Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export. J Biol Chem 2002; 277: 37401–37405.

    Article  CAS  PubMed  Google Scholar 

  151. Hou Y, Wu Y, Farooq SM, Guan X, Wang S, Liu Y et al. A critical role of CXCR2 PDZ-mediated interactions in endothelial progenitor cell homing and angiogenesis. Stem Cell Res 2015; 14: 133–143.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

THB was supported by the ‘Ministère de l’Enseignement Supérieur et de la Recherche’, Fondation de France No. 2011-00025574 and Fondation ARC No. DOC20130606463. LF is supported by grants from Fondation de France (No. 2014 00047502), La Ligue National contre le Cancer (No. RS14/75-112) and GEFLUC. JV is recipient of two following postdoctoral fellowships from the Spanish Association for the Study of the Liver (AEEH) and the Fondation ARC No. PDF2014601431. The authors thank Yves Chrétien for the graphic support.

Author information

Authors and Affiliations

  1. Sorbonne Universités, UPMC Univ Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France

    J Vaquero, T H Nguyen Ho-Bouldoires, A Clapéron & L Fouassier

  2. FONDATION ARC, Villejuif, France

    J Vaquero & T H Nguyen Ho-Bouldoires

Authors
  1. J Vaquero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T H Nguyen Ho-Bouldoires
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Clapéron
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L Fouassier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L Fouassier.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vaquero, J., Nguyen Ho-Bouldoires, T., Clapéron, A. et al. Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance. Oncogene 36, 3067–3079 (2017). https://doi.org/10.1038/onc.2016.462

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2016.462

This article is cited by

Search

Advanced search

Quick links